Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v3-EN
Language English English
Date Updated 2020-08-06 2020-07-14
Drug Identification Number 02245248 02245248
Brand name AMIODARONE HYDROCHLORIDE INJECTION AMIODARONE HYDROCHLORIDE INJECTION
Common or Proper name Amiodarone Hydrochloride for Injection Amiodarone Hydrochloride for Injection
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE
Strength(s) 50MG 50MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 50 mg/mL, MD Vial 3 mL 50 mg/mL, MD Vial 3 mL
ATC code C01BD C01BD
ATC description ANTIARRHYTHMICS, CLASS I AND III ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-07-13 2020-07-13
Actual start date
Estimated end date 2020-08-21 2020-08-21
Actual end date 2020-08-05
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Amiodarone Hydrochloride for Injection, 50 mg/mL, MD Vial 3 mL are now available at all distribution centres effective today, August 5, 2020. Please note that this product will remain on allocation. Contract customers will receive 100% of their historical monthly average volumes. Fresenius Kabi Canada Ltd. regrets to advise that due to a delay in production we will be encountering a supply interruption on our Amiodarone Hydrochloride for Injection, 50 mg/mL, 3 mL Vial. The product will remain on 100% allocation until stock is depleted
Health Canada comments